BOTHELL, WA - July 16, 2007 - Sonosite, Inc., (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced the closing of its offering of $200 million aggregate principal amount of Convertible Senior Notes due 2014 in an offering registered under the Securities Act of 1933 as amended (the "Securities Act"). The notes will pay interest semiannually at a rate of 3.75% per annum. In certain circumstances, the notes will be convertible based on an initial conversion rate of 26.1792 shares of common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $38.20 per share. Conversions will be settled in cash up to the principal amount of the notes, with any conversion value above the principal amount settled in shares of Sonosite's common stock. Holders of the notes may require Sonosite to repurchase the notes for cash equal to 100% of the principal amount to be repurchased plus accrued and unpaid interest upon the occurrence of a fundamental change. Sonosite has granted the underwriters a 30-day option to purchase up to $25 million in aggregate principal amount of additional notes to cover over-allotments.… [Read more]
Judge Reverses Earlier Infringement RulingGrants Sonosite Motion For Summary Judgment
BOTHELL, WA - March 22, 2006 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, announced today that the United States District Court for the Southern District of Texas, Houston Division, has granted Sonosite's motion for summary judgment of invalidity against Neutrino Development Corporation (Neutrino), a patent holding company. Based on the holding of invalidity, the court reversed its earlier finding that Sonosite infringed Neutrino's patent, US Patent No. 6,221,021 ("the '021 patent").
"This is a major victory for Sonosite and we are very pleased that the judge agreed with us that our products do not infringe Neutrino's patent," said Kevin M. Goodwin, Sonosite President and CEO. "Our technology and products are based on years of innovation and dedication by our employees. We look forward to having the distraction of this unfounded lawsuit behind us and continuing to develop products that are changing medical practice by bringing the benefits of ultrasound visualization to the point of patient care."
In the ruling issued yesterday, March 21, 2006, the court found that Neutrino improperly amended the '021 patent in violation of US patent law to include a claim of a component being handheld which was not in the original patent application.… [Read more]
Leading Health Care Group Purchasing Organization Adds State-of-Art Hand-Carried Ultrasound Systems to its National Contract PortfolioBOTHELL, WA - August 30, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, today announced it has signed a three-year, dual-source supply agreement with Novation for portable and vascular access ultrasound equipment and accessories. Novation is the supply company of VHA Inc. and the University Health System Consortium (UHC), two national health care alliances that serve approximately 2,500 health care providers nationwide. "We awarded this agreement to Sonosite based on member surveys, the recommendation of our member-based Diagnostic Imaging Capital Equipment task force and a public competitive bid process," said Cynthia Longueville, Novation senior product manager. "Novation looks forward to working with Sonosite to provide VHA and UHC members products that offer the best combination of quality, service and value."… [Read more]
BOTHELL, WA - August 10, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, announced today the appointment of Graham D. Cox as Vice President of its international business. Henry (Skip) A. Krause, who has led Sonosite's international division for the past two years, is resigning his position for personal family reasons, effective September 12, 2005."Skip has made significant contributions to expanding our presence into new international markets and successfully re-engineered our distribution in Japan," said Kevin M. Goodwin, Sonosite President and CEO. "We appreciate his efforts and wish Skip and his family all the best in the future.""We are fortunate to have an executive of Graham Cox's caliber and ultrasound experience who is well qualified to immediately assume leadership of our international business," Goodwin said. "Graham's proven leadership in establishing and growing our operations in Europe, Africa and the Middle East, provides an excellent base from which to lead and maintain our strong momentum in international markets."… [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, WA - April 14, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that the Company will report its first quarter financial results on Thursday, April 28, 2005 at the close of market and hold a conference call at 1:30 pm PT/4:30 pm ET to discuss its first quarter performance, outlook for 2005 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com.A replay of the audio webcast will be available beginning April 28, 2005, 4:30 pm (PT) until May 11, 2005, 12:00 midnight (PT) by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7405545 is required to access the replay. The call will be also archived on the Sonosite website.About Sonosite… [Read more]
Revolutionary Combination of Cost, Performance and Size Promises to Bring Benefits of Ultrasound to More Doctors and PatientsCustomer Shipments to begin in JuneBOTHELL, WA - April 18, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced the worldwide launch of its MicroMaxx„¢ ultrasound system, the company's third generation hand-carried product. The MicroMaxx system, at less than eight pounds and the size of a laptop computer, delivers image resolution and performance comparable to costly, conventional cart-based ultrasound systems weighing over 200 pounds. This unprecedented power in a hand-carried configuration provides caregivers with unmatched flexibility and efficiency in utilizing ultrasound in both hospital and office-based settings.… [Read more]
Sonosite Hand-carried Ultrasound Systems Integral Part of Medical Support at the Winter Games… [Read more]
BOTHELL, WA, July 30, 2002 - Sonosite, Inc. (Nasdaq: SONO) today announced that, effective August 5, Jens U. Quistgaard, Ph.D., Sonosite's chief product and strategy officer, will leave the Company to become the president and chief executive officer of LipoSonix, Inc., a private company based in the Seattle area.
LipoSonix is developing medical devices for cosmetic surgery applications and is not a Sonosite competitor. "Jens has been with Sonosite since the beginning when we were the Handheld Systems Business Group at ATL Ultrasound five years ago," said Kevin M. Goodwin, Sonosite's president and CEO.
"Under his leadership, our product development and marketing groups have delivered ground-breaking products and strong market progress. Jens deserves an opportunity like this, and we wish him the best. "Blake Little, vice president of engineering, will become the Company's senior engineering officer and technology spokesperson," Goodwin continued. "Blake has been instrumental in the development and release of all of Sonosite's products, including our newest product line that we will be launching in the next several weeks.… [Read more]
A Tool to Improve Post-Operative Surgical Outcomes and Reduce Hospital Costs
Non-invasive System to Assist in Fluid Management
Technology Debuts at the 2011 American Society of Anesthesiologists Conference (ASA) October 15-17th, Booth #2242
BOTHELL, WA - October 13, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today introduced the new BioZ® Cardio Profile system with impedance cardiography (ICG) technology for non-invasively monitoring a patient's hemodynamic profile in the hospital. Pioneered by NASA in the 1960's, ICG hemodynamic monitoring has traditionally been used to treat patients with heart failure and hypertension, and it is now ready to play a significant role in the anesthesia suite.… [Read more]
BOTHELL, WA—October 6, 2011—Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that it will report the company's third quarter financial results on Tuesday, October 25, 2011 at the close of market and will host a conference call at 1:30 pm PT/4:30 ET. The call will be broadcast live and can be accessed via Sonosite's website at http://www.sonosite.com/about/investors.
A replay of the audio webcast will be available beginning October 25th at 4:30 pm PT and will be available until November 8th at 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7745091 is required to access the replay. The call will also be archived on Sonosite's website.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
BOTHELL, WA - July 29, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced the appointments of Thomas J. Dugan as Senior Vice President, Marketing and Robert L. Massa as Vice President, Corporate Accounts.
Mr. Dugan brings 24 years of experience in marketing, sales, business development and operations in the medical device industry to Sonosite. He is currently a member of the Board of Directors for RITA Medical Systems, a medical device company focused on innovative oncology therapies, and a consultant to several medical device companies. From 2002 to 2004, Mr. Dugan was President of InterVascular, Inc., a subsidiary of Datascope Corporation and was a corporate officer of Datascope. He also served as corporate vice president of business development for Datascope from 2001 to 2002. From 1999 to 2001, Mr. Dugan was vice president of marketing for United States Surgical, a division of Tyco Healthcare, and responsible for their Auto Suture and USS/D&G Suture businesses. From 1996 to 1999, he headed business development for United States Surgical during a period when it made numerous acquisitions, investments and divestitures. Mr. Dugan has held management positions in sales, marketing and international with C.R. Bard, Puritan-Bennett and Johnson & Johnson.… [Read more]
Hand Carried Ultrasound System Is Honored In the "Facilities and Systems for Medical Institutions" Category BOTHELL, WA - November 18, 2005 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced that its MicroMaxx ultrasound system has won a 2005 Good Design Award (G-mark) in Japan. As one of 20 winning products in the category of "Facilities and Systems for Medical Institutions," the MicroMaxx system can display the G-Mark, a widely recognized label of design excellence in Japan and by designers worldwide.
Sponsored by the Japan Industrial Design Promotion Organization (JIDPO), a non-profit organization established by the Japanese Ministry of Economy, Trade and Industry, the annual competition has issued Good Design Awards for the past 50 years. The mission of the awards is to recognize those products that are expected to enrich peoples' lives through innovative design that advances society. Screening for this year's awards was conducted from July to September by a jury of designers, architects and others who represent the world of Japanese design and are at the forefront of their respective fields.… [Read more]
US and Canada's Space Agencies Testing Medical Technology In Ninth Undersea Mission BOTHELL, WA and TORONTO - November 28, 2005 ' Sonosite Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, said today that the MicroMaxx system, the company's third generation ultrasound product, will be used to demonstrate that successful emergency treatment of a musculoskeletal injury during simulated space flight conditions can be accomplished with telementoring.
The test will be conducted during an 18-day experiment on the ninth mission of NASA Extreme Environment Mission Operations, or NEEMO 9, under 19 meters of water near Key Largo, Florida, in a habitat called Aquarius, which is analogous to a habitat that would house astronauts on the Earth's moon. Each aquanaut will use the notebook-sized MicroMaxx system to perform a diagnostic ultrasound of an injured knee prosthetic at the direction of radiologists and surgeons at the Center for Minimal Access Surgery at McMaster University in Ontario.… [Read more]
BOTHELL, WA - January 2, 2007 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, announced today that Kevin M. Goodwin, Sonosite President and CEO will present at the 25th Annual JPMorgan Healthcare Conference at the Westin St. Francis in San Francisco on Tuesday, January 9, 2007 at 10:30 am (PT). A link to the audio-only webcast and replay will be available at http://ir.sonosite.com. The replay will be available beginning January 10, 2007 at 10:30 am (PT) and ending at midnight April 9, 2007.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 25,000 systems. The company, headquartered near Seattle, is represented by eight subsidiaries and a global distribution network in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 500 people worldwide.… [Read more]
New needle guidance solution helps make central venous catheter procedures "point-and-shoot" simple to improve care quality and reduce healthcare costs
BOTHELL, WA (September 13, 2012) – Sonosite, Inc., a subsidiary of FUJIFILM Corporation and the world leader and specialist in bedside and point-of-care ultrasound, today announced a partnership with Soma Access Systems LLC to bring AxoTrack™ needle visualization technology to market on Sonosite ultrasound systems. This innovative technology combines traditional ultrasound imaging with advanced magnetics to provide clinicians with a real-time update of the needle position that can be visualized as it travels through tissue to its intended target. This capability is ideal for placing central venous catheters (CVC) as clinicians try to quickly gain vascular access while avoiding critical structures.1… [Read more]
Introducing a New Care Path Strategy to Reduce Complications and Costs
Ultrasound-Guided Peripheral IVs Replace High-Risk Central Venous Catheter Line Placements in 84% of Patients
BOTHELL, WA– November 8, 2012– FUJIFILM Sonosite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, announces new patient safety data achieved by Thomas Jefferson University Hospitals, Inc. (TJUH), a 957-bed academic medical center located in Philadelphia. Arthur Au, MD, a Clinical Instructor at Jefferson Medical College and Emergency Medicine physician at TJUH presented new data from an internal ultrasound-guidance study at the 2011 American College of Emergency Physicians (ACEP) conference.
Discovering a New Care Path Strategy
The goal of the study at TJUH was to determine if the number of Central Venous Catheter (CVC) placements could be reduced or replaced with a safer alternative− ultrasound-guided peripheral intravenous (USGPIVs) in patients with difficult IV access. The clinical challenge with most patients entering the emergency department includes: obesity, edema, or small veins that are difficult to visualize, making it incredibly difficult for a physician or nurse to place a peripheral IV.… [Read more]
BOTHELL, WA– December 13, 2012- FUJIFILM Sonosite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, recognizes Life Line Screening for providing access to preventive screening services and encouraging millions of people to take a proactive approach to their health. With point-of-care ultrasound visualization, Life Line Screenings' clinicians are able to look inside a patient’s body to identify disease that could otherwise remain asymptomatic and undetected. As a leading provider of community based preventive health screening events for almost 20 years, Life Line Screening has administered over seven million screenings.… [Read more]
Sonosite's X-Porte™ Ultrasound Kiosk integrates advanced signal processing for high-resolution imaging, 3D animated clinical guides, and a cutting-edge multi-gesture user interface—all first-ever innovations in point-of-care ultrasound
BOTHELL, WA – November 8, 2013 – FUJIFILM Sonosite, Inc., specialists in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced it received 510(k) clearance from the FDA for its newest generation of point-of-care ultrasound: the X-Porte™ Ultrasound Kiosk. Available in a stationary or a detachable use model, Sonosite will begin shipping the X-Porte kiosk in the United States effective immediately. The X-Porte is already available in parts of Europe and Asia-Pacific.
"This is a major accomplishment for Sonosite and a defining moment in the next phase of our innovation strategy," says Sonosite President and CEO Kevin M. Goodwin. "Working side-by-side with hundreds of clinicians from the frontlines of medicine worldwide, we combined their many insights with the most innovative consumer technologies available today. Then, we blended in our own inspiration from key engineers at our company, creating a remarkable new tool built from the ground up."… [Read more]
New open-access VividTrac® device—for “where you need it, when you need it” intubation—
brings video intubation to the forefront of patient care
BOTHELL, WA, January 14, 2014 – FUJIFILM Sonosite, Inc., the world leader and pioneering specialist in bedside and point-of-care ultrasound, today announced a partnership with Vivid Medical Inc. of Palo Alto, CA, to co-promote the VividTrac® Video Intubation Device. VividTrac is the world’s first and only single-use, "open access” video intubation device with a USB interface that connects easily to a variety of display options. By simply plugging the VividTrac device into a compatible system, clinicians will have access to high-resolution video intubation to enhance patient safety and care.… [Read more]